Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Net sales $ 78,777,976 $ 71,893,763 $ 163,581,808 $ 130,374,365
Cost of sales 70,940,204 56,177,441 147,060,382 103,424,624
Gross profit 7,837,772 15,716,322 16,521,426 26,949,741
Selling, general and administrative expense 7,663,317 7,738,752 16,558,445 13,594,872
Acquisition related costs 20,073 690,217 348,021 690,217
Earn-out adjustments (417,808) 2,307,598 (401,285) 2,461,658
Operating income 572,190 4,979,755 16,245 10,202,994
Other expense (income)        
Interest expense 1,009,797 403,852 2,033,738 717,835
Change in fair value of interest rate swaps 76,533 (19,255) 124,094 (92,458)
Other, net (109,773) (59,111) (404,441) 29,185
(Loss) income before income taxes (404,367) 4,654,269 (1,737,146) 9,548,432
Income tax (benefit) provision (141,629) 976,998 (547,886) 2,035,998
Net (loss) income $ (262,738) $ 3,677,271 $ (1,189,260) $ 7,512,434
Net (loss) income per common share:        
Basic (in dollars shares) $ (0.03) $ 0.42 $ (0.13) $ 0.86
Diluted (in dollars shares) $ (0.03) $ 0.41 $ (0.13) $ 0.85
Weighted average shares outstanding:        
Basic (in shares) 8,974,212 8,776,239 8,950,563 8,761,182
Dilutive effect from stock options and grants (in shares) 0 87,537 0 72,804
Diluted (in shares) 8,974,212 8,863,776 8,950,563 8,833,986